Instil Bio (TIL) Competitors $17.57 -0.09 (-0.51%) Closing price 09/24/2025 04:00 PM EasternExtended Trading$18.01 +0.44 (+2.50%) As of 09/24/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TIL vs. SIGA, SEPN, KROS, SNDL, TERN, PVLA, ORGO, GHRS, BCAX, and SVRAShould you be buying Instil Bio stock or one of its competitors? The main competitors of Instil Bio include Siga Technologies (SIGA), Septerna (SEPN), Keros Therapeutics (KROS), SNDL (SNDL), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Organogenesis (ORGO), GH Research (GHRS), Bicara Therapeutics (BCAX), and Savara (SVRA). These companies are all part of the "pharmaceutical products" industry. Instil Bio vs. Its Competitors Siga Technologies Septerna Keros Therapeutics SNDL Terns Pharmaceuticals Palvella Therapeutics Organogenesis GH Research Bicara Therapeutics Savara Siga Technologies (NASDAQ:SIGA) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment. Is SIGA or TIL more profitable? Siga Technologies has a net margin of 45.73% compared to Instil Bio's net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat Instil Bio's return on equity.Company Net Margins Return on Equity Return on Assets Siga Technologies45.73% 40.52% 35.62% Instil Bio N/A -54.32%-33.65% Do institutionals & insiders hold more shares of SIGA or TIL? 55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 60.6% of Instil Bio shares are owned by institutional investors. 2.0% of Siga Technologies shares are owned by company insiders. Comparatively, 47.2% of Instil Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, SIGA or TIL? Siga Technologies has higher revenue and earnings than Instil Bio. Instil Bio is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiga Technologies$138.72M4.60$59.21M$1.137.88Instil BioN/AN/A-$74.14M-$12.92-1.36 Which has more risk and volatility, SIGA or TIL? Siga Technologies has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Instil Bio has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Do analysts rate SIGA or TIL? Instil Bio has a consensus target price of $88.50, suggesting a potential upside of 403.70%. Given Instil Bio's stronger consensus rating and higher probable upside, analysts clearly believe Instil Bio is more favorable than Siga Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Instil Bio 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media prefer SIGA or TIL? In the previous week, Siga Technologies had 3 more articles in the media than Instil Bio. MarketBeat recorded 4 mentions for Siga Technologies and 1 mentions for Instil Bio. Siga Technologies' average media sentiment score of 1.32 beat Instil Bio's score of 0.00 indicating that Siga Technologies is being referred to more favorably in the media. Company Overall Sentiment Siga Technologies Positive Instil Bio Neutral SummarySiga Technologies beats Instil Bio on 9 of the 16 factors compared between the two stocks. Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIL vs. The Competition Export to ExcelMetricInstil BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$119.22M$3.15B$5.77B$10.42BDividend YieldN/A2.36%5.68%4.62%P/E Ratio-1.3620.7676.2826.42Price / SalesN/A444.32553.28128.19Price / CashN/A45.9137.5661.52Price / Book0.689.8313.186.39Net Income-$74.14M-$52.73M$3.29B$271.13M7 Day Performance-16.45%1.84%0.84%0.93%1 Month Performance-31.66%7.48%5.03%7.52%1 Year Performance-74.57%19.92%71.27%30.06% Instil Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TILInstil Bio2.6295 of 5 stars$17.57-0.5%$88.50+403.7%-74.3%$119.22MN/A-1.36410SIGASiga Technologies2.0602 of 5 stars$9.00+0.9%N/A+11.2%$638.73M$138.72M7.9640SEPNSepterna1.4971 of 5 stars$14.47+1.3%$26.75+84.9%N/A$636.68M$1.08M-1.43N/AKROSKeros Therapeutics3.2962 of 5 stars$15.55-0.7%$30.00+92.9%-71.7%$636.03M$232.84M50.16100Positive NewsSNDLSNDL3.8071 of 5 stars$2.50+3.7%$4.50+80.0%+26.0%$633.29M$671.81M-9.262,516Positive NewsTERNTerns Pharmaceuticals4.0733 of 5 stars$7.13-1.4%$15.61+118.9%-18.1%$632.71MN/A-6.8640PVLAPalvella Therapeutics2.0868 of 5 stars$54.63-3.9%$60.91+11.5%N/A$628.63M$42.81M-4.51N/ANews CoverageAnalyst ForecastORGOOrganogenesis3.933 of 5 stars$4.96+0.6%$7.50+51.2%+68.4%$625.41M$429.31M-35.43950Positive NewsGHRSGH Research2.2444 of 5 stars$13.11+9.8%$32.00+144.1%+90.0%$621.22MN/A-17.7210BCAXBicara Therapeutics2.1876 of 5 stars$11.38-2.1%$32.25+183.4%-56.5%$620.93MN/A-3.5932Positive NewsSVRASavara2.6186 of 5 stars$3.61+1.4%$7.50+107.8%-20.6%$615.30MN/A-7.2220Trending News Related Companies and Tools Related Companies SIGA Competitors SEPN Competitors KROS Competitors SNDL Competitors TERN Competitors PVLA Competitors ORGO Competitors GHRS Competitors BCAX Competitors SVRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TIL) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TIL Stock Alerts